Avisi Technologies Eyes Goal of Human Trials with $1M National Science Foundation Grant

September 21, 2020

RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) — funds cofounder Rui Jing Jiang said will go toward bringing the startup’s research to life in preclinical work. The […]

Read More

Money Moves: 3 Life Science and Health IT Companies Raise Funds — and One Goes Public

August 24, 2020

TrekIT Health, creators of a digital platform through which an entire medical team could access documents and care instructions for patients, has raised $1 million in additional seed funding. The round was led by Tech Council Ventures with participation from Boston Millennia Partners Founders Fund and Front Row Fund, who join existing investors including IP […]

Read More

Strados Labs Awarded Competitive Small Business Innovation Grant from the National Science Foundation

August 18, 2020

Strados Labs has been awarded a National Science Foundation (NSF) Phase I Small Business Innovation Research (SBIR) grant for $224,470 to conduct research and development (R&D) work on a smart wearable platform for remote respiratory monitoring: building better technologies for telemedicine in the age of COVID-19. This leading-edge technology from Strados Labs is used to […]

Read More

InfraScan Inc. Announces Issuance of US Patents for Brain Diagnosis

August 4, 2020

InfraScan, a medical device firm specializing in brain injury and stroke diagnostic products, announced today the issuance by the US Patent Office of three additional patents that cover internal bleeding, brain trauma and stroke detection technologies. The first patent for invention number US 2020/0229712 A1 is for an optical probe for oximetry measurements. The second […]

Read More

Biopharma Tackles COVID-19, HIV and Other Viruses with Gene and Cell Therapies

July 27, 2020

Deploying CRISPR against hidden HIV reservoirs Excision BioTherapeutics is applying both CRISPR and AAV delivery toward solving a different but equally vexing problem in antiviral drug development: HIV. Even though antiretroviral drugs can tamp down the virus to the point where it’s no longer detectable in the blood, it can hide out in “reservoirs” and […]

Read More

Can an Animal Vaccine Developer be the One to Tame Covid-19? MBF Therapeutics Places its Bet

July 23, 2020

MBF Therapeutics, which to date has focused on developing DNA-based vaccines for animals, said Thursday it has formed a collaboration with four life science industry partners to work on a Covid-19 vaccine for humans. The collaboration with MRIGlobal, Rymedi, SSI Strategy and Aldevron will seek to advance MBF Therapeutics’ SARS CoV-2 vaccine candidate COVE-001. Financial […]

Read More

NextUp: The Philly Company Improving Rapid Molecular Tests for COVID-19

July 13, 2020

Who: Marc DeJohn, Jesse vanWestrienen and Max Perelman are the co-founders of the Philadelphia-based biotech company, Biomeme, home of the first iPhone add-on capable of performing molecular tests. It all started with an idea, an iPhone and a hairdryer. The trio had a shared interest in personal health and wanted to give individuals access to […]

Read More

NextUp: The Local Company Unlocking the Mysteries of Brain Disease

June 30, 2020

Who: Maria Maccecchini was a young scientist in her early twenties when she first became fascinated with the idea of cell death, the process through which human cells stop functioning. At the time, science students like Maccecchini were taught that while most human cells, like skin cells, can divide or replace themselves many times before […]

Read More

Wistar Institute Will use 3D-Printed Lung Models Made by Allevi for Coronavirus Research

June 30, 2020

Pennovation-based life sciences technology company Allevi is partnering with University City-based biomedical research center The Wistar Institute to use 3D printing to learn about COVID-19. COVID-19 is an acute respiratory illness and has taken more than 500,000 lives worldwide. Allevi’s patented 3D bioprinting platform will create 3D models of lungs for Wistar scientists to use […]

Read More

University of Kentucky, Children’s Hospital of Philadelphia and Mitochon Pharmaceuticals Awarded NIH Grant for Traumatic Brain Injury Studies

June 23, 2020

Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI). This important award, along with the Company’s open IND, will help pave the […]

Read More